TOMANIN, ROSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.092
EU - Europa 294
AS - Asia 152
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 2.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.092
CN - Cina 113
IT - Italia 83
SE - Svezia 83
FI - Finlandia 43
DE - Germania 25
VN - Vietnam 20
UA - Ucraina 18
GB - Regno Unito 17
IN - India 14
IE - Irlanda 7
JP - Giappone 3
ES - Italia 2
FR - Francia 2
RU - Federazione Russa 2
SI - Slovenia 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
KR - Corea 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
PT - Portogallo 1
Totale 2.541
Salva come PNG Salva come JPEG
Città #
Fairfield 316
Houston 270
Chandler 209
Ann Arbor 186
Woodbridge 171
Ashburn 137
Seattle 129
Cambridge 120
Wilmington 120
Jacksonville 49
Padova 46
Beijing 45
Princeton 38
San Diego 29
Des Moines 25
Helsinki 24
Medford 24
Dong Ket 20
New York 19
Nanjing 18
Boardman 13
Falls Church 9
Dublin 7
Roxbury 7
Milan 6
Pune 6
Shenyang 6
Brissago Valtravaglia 5
Jinan 5
Vicenza 5
Munich 4
Auburn Hills 3
Changsha 3
Nanchang 3
Ogden 3
Selvazzano Dentro 3
Tappahannock 3
Tokyo 3
Aprilia 2
Borås 2
Fremont 2
Haikou 2
Kharkiv 2
Lanzhou 2
Los Angeles 2
Neustadt am Ruebenberge 2
Phoenix 2
Bologna 1
Brussels 1
Budapest 1
Camposampiero 1
Chicago 1
Chioggia 1
Chongqing 1
Cochabamba 1
Durham 1
Edinburgh 1
Guangzhou 1
Gunzenhausen 1
Hebei 1
Hefei 1
Huzhou 1
Il-Madliena 1
Indiana 1
Jakarta 1
Jiaxing 1
Jinhua 1
Kilburn 1
Lisbon 1
Luxembourg 1
Ningbo 1
Norwalk 1
Pescara 1
Redwood City 1
Rimini 1
Rockville 1
Rome 1
San Francisco 1
Sant'elena 1
Shanghai 1
Sofia 1
St Louis 1
Sydney 1
Taizhou 1
Tallinn 1
Teaneck 1
Tianjin 1
Vienna 1
Wandsworth 1
Washington 1
Zhengzhou 1
Totale 2.151
Salva come PNG Salva come JPEG
Nome #
Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II 174
High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors 166
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment 148
QueryOR: a comprehensive web platform for genetic variant analysis and prioritization 132
RNA-seq Transcriptome Profiling Of Primary Hunter Cells Following Treatment With Recombinant IDS As A First Step For Identification Of ERT Efficacy Markers 129
Gene therapy of Hunter syndrome: Evaluation of the efficiency of muscle electro genetransfer for the production and release of recombinant iduronate-2-sulfatase (IDS) 119
A Hunter Patient with a Severe Phenotype Reveals Two Large Deletions and Two Duplications Extending 1.2 Mb Distally to IDS Locus 107
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders 102
A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders. 101
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model 99
Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts 97
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 94
Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction 87
FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII). 86
Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro 86
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. 85
A rapid testing procedure for Fabry disease: alpha-galadosidase A assay in dried blood spots 80
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach 75
Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years 75
Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases. 62
Antiretroviral activity of furocoumarins plus UVA light detected by a replication-defective retrovirus 62
Targeting brain disease in MPSII: Preclinical evaluation of IDS-loaded PLGA nanoparticles 62
Rapid diagnostic testing procedures for lysosomal storage disorders: alpha-glucosidase and beta-galactosidase assays on dried blood spots 45
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study 38
Evaluation of the antiviral activity of psoralens. G. Miolo, R. Tomanin, A. De Rossi, F. Dall'Acqua, F. Zacchello, M. Scarpa. 37
Exploiting the potential of drosophila models in lysosomal storage disorders: Pathological mechanisms and drug discovery 37
Drosophila d-idua reduction mimics mucopolysaccharidosis type i disease-related phenotypes 37
Setup and Validation of a Targeted Next-Generation Sequencing Approach for the Diagnosis of Lysosomal Storage Disorders 36
A replication defective retrovirus model for the identification of psoralens with antiretroviral activity. 31
Mucopolysaccharidosis type II: One hundred years of research, diagnosis, and treatment 26
Early axon guidance and synapse maturation defects in a zebrafish model of Mucopolysaccharidosis type II 15
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy 15
Corrigendum: FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII) [Human Molecular Genetics, 27, 13, (2018) (2262-2275)] DOI: 10.1093/hmg/ddy131 14
A novel CRISPR/Cas9-based iduronate-2-sulfatase (IDS) knockout human neuronal cell line reveals earliest pathological changes 10
Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study 9
Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans-A Diagnostic Prediction Model 4
Totale 2.582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.133
article - articoli 8.826
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019169 0 0 0 0 0 0 0 0 0 44 73 52
2019/2020536 55 13 28 67 52 35 43 54 55 68 51 15
2020/2021411 23 15 31 24 15 31 11 31 53 105 33 39
2021/2022477 22 37 57 30 64 36 30 34 36 9 41 81
2022/2023414 59 40 9 58 45 66 0 41 56 8 27 5
2023/2024195 11 36 30 22 17 36 20 15 4 4 0 0
Totale 2.582